Loading clinical trials...
Loading clinical trials...
The purpose of this survey is to collect detailed information on patients treated for blepharospasm with incobotulinumtoxinA, abobotulinumtoxinA and onabotulinumtoxinA, including how often they are tr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merz Pharmaceuticals GmbH
Collaborators
NCT07489430 · Blepharospasm of Both Eyelids, Blepharospasm of Left Eyelid, and more
NCT03938363 · Cervical Dystonia, Primary, Blepharospasm
NCT05618470 · Dry Eye Syndromes, Meige Syndrome, and more
NCT03903341 · Blepharospasm, Benign Essential
NCT02577224 · Blepharospasm, Hemi Facial Spasm
Merz Investigative Site #0007
Fountain Valley, California
Merz Investigative Site # 0002
Sarasota, Florida
Merz Investigative Site # 0001
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions